- Corporate Officers - S
- Sanofi
Insider Trading History of Sanofi
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sanofi since 2013.
This trader's CIK number is 1121404.
At the time of last reporting, Sanofi was the 10% Owner of Translate Bio, Inc.. (stock ticker symbol TBIO).
Also see all insider trading activities at Translate Bio, Inc..
Note that in the past
Sanofi also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Icosavax, Inc. (ICVX) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | ICVX | 66,667 | $1,000,005 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Fulcrum Therapeutics, Inc. (FULC) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | FULC | 93,750 | $1,500,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inozyme Pharma, Inc. (INZY) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | INZY | 81,250 | $1,300,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Humanigen, Inc (KBIO) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | KBIO | 87,500 | $700,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Myokardia, Inc. (MYOK) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | MYOK | 0 | $0 | 4,168,899 | $157,000,736 | 0 | $0 |
2018 | MYOK | 150,000 | $7,350,000 | 0 | $0 | 0 | $0 |
2017 | MYOK | 350,000 | $12,425,000 | 0 | $0 | 0 | $0 |
2016 | MYOK | 450,000 | $6,750,000 | 0 | $0 | 0 | $0 |
2015 | MYOK | 900,000 | $9,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Regeneron Pharmaceuticals, Inc. (REGN) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | REGN | 0 | $0 | 23,070,599 | $11,770,477,328 | 0 | $0 |
2019 | REGN | 0 | $0 | 304,019 | $102,653,062 | 0 | $0 |
2018 | REGN | 0 | $0 | 226,153 | $80,131,125 | 0 | $0 |
2017 | REGN | 462,141 | $212,021,764 | 0 | $0 | 0 | $0 |
2016 | REGN | 148,669 | $62,482,433 | 0 | $0 | 0 | $0 |
2015 | REGN | 249,426 | $126,235,455 | 0 | $0 | 0 | $0 |
2014 | REGN | 6,428,301 | $2,018,253,320 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Regulus Therapeutics Inc. (RGLS) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | RGLS | 1,303,780 | $9,999,992 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | ALNY | 297,501 | $21,381,396 | 0 | $0 | 0 | $0 |
2016 | ALNY | 205,030 | $14,300,842 | 0 | $0 | 0 | $0 |
2015 | ALNY | 940,817 | $1,899,204,337 | 0 | $0 | 0 | $0 |
2014 | ALNY | 344,448 | $23,036,682 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Voyager Therapeutics, Inc. (VYGR) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | VYGR | 125,000 | $1,750,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Translate Bio, Inc. (TBIO) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | TBIO | 71,983,597 | $2,735,376,686 | 0 | $0 | 0 | $0 |
Insider trading activities at 10 companies by Sanofi:
1. Icosavax, Inc. (ICVX)
2. Fulcrum Therapeutics, Inc. (FULC)
3. Inozyme Pharma, Inc. (INZY)
4. Humanigen, Inc (KBIO)
5. Myokardia, Inc. (MYOK)
6. Regeneron Pharmaceuticals, Inc. (REGN)
7. Regulus Therapeutics Inc. (RGLS)
8. Alnylam Pharmaceuticals, Inc. (ALNY)
9. Voyager Therapeutics, Inc. (VYGR)
10. Translate Bio, Inc. (TBIO)
Table 1. Insider trading of Icosavax, Inc. (ICVX) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-08-02 | ICVX | Buy | 66,667 | 15.00 | 1,000,005 |
Table 2. Insider trading of Fulcrum Therapeutics, Inc. (FULC) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-07-22 | FULC | Buy | 93,750 | 16.00 | 1,500,000 |
Table 3. Insider trading of Inozyme Pharma, Inc. (INZY) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-07-28 | INZY | Buy | 81,250 | 16.00 | 1,300,000 |
Table 4. Insider trading of Humanigen, Inc (KBIO) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-01-31 | KBIO | Buy | 87,500 | 8.00 | 700,000 |
Table 5. Insider trading of Myokardia, Inc. (MYOK) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-02-13 | MYOK | Sale | 4,168,899 | 37.66 | 157,000,736 |
2018-05-25 | MYOK | Buy | 150,000 | 49.00 | 7,350,000 |
2017-08-14 | MYOK | Buy | 350,000 | 35.50 | 12,425,000 |
2016-10-03 | MYOK | Buy | 450,000 | 15.00 | 6,750,000 |
2015-11-03 | MYOK | Buy | 900,000 | 10.00 | 9,000,000 |
Table 6. Insider trading of Regeneron Pharmaceuticals, Inc. (REGN) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-06-09 | REGN | Sale | 120,234 | 597.48 | 71,837,410 |
2020-05-29 | REGN | Sale | 22,821,451 | 509.85 | 11,635,516,792 |
2020-03-09 | REGN | Sale | 128,914 | 489.65 | 63,123,126 |
2019-09-10 | REGN | Sale | 172,904 | 281.15 | 48,611,786 |
2019-03-08 | REGN | Sale | 131,115 | 412.17 | 54,041,276 |
2018-09-06 | REGN | Sale | 104,552 | 406.68 | 42,519,207 |
2018-06-08 | REGN | Sale | 121,601 | 309.31 | 37,611,918 |
2017-08-25 | REGN | Buy | 72,378 | 482.99 | 34,957,488 |
2017-08-23 | REGN | Buy | 60,595 | 478.30 | 28,982,467 |
2017-08-24 | REGN | Buy | 105,820 | 481.79 | 50,983,335 |
2017-06-02 | REGN | Buy | 136,050 | 475.63 | 64,709,869 |
2017-01-11 | REGN | Buy | 87,298 | 371.01 | 32,388,605 |
2016-06-14 | REGN | Buy | 64,731 | 364.22 | 23,576,583 |
2016-01-12 | REGN | Buy | 83,938 | 463.51 | 38,905,850 |
2015-10-06 | REGN | Buy | 11,040 | 473.60 | 5,228,532 |
2015-10-06 | REGN | Buy | 80,538 | 459.17 | 36,980,633 |
2015-09-23 | REGN | Buy | 147,209 | 532.00 | 78,315,924 |
2015-07-27 | REGN | Buy | 10,639 | 536.74 | 5,710,366 |
2014-12-23 | REGN | Buy | 171,457 | 391.47 | 67,119,585 |
2014-12-24 | REGN | Buy | 30,002 | 396.41 | 11,893,032 |
2014-10-16 | REGN | Buy | 122,127 | 334.12 | 40,804,828 |
2014-10-15 | REGN | Buy | 158,368 | 329.35 | 52,157,867 |
2014-09-16 | REGN | Buy | 31,717 | 348.94 | 11,067,171 |
2014-09-15 | REGN | Buy | 80,824 | 343.90 | 27,795,454 |
2014-09-12 | REGN | Buy | 59,808 | 346.50 | 20,723,172 |
2014-07-15 | REGN | Buy | 129,100 | 315.06 | 40,674,246 |
2014-07-11 | REGN | Buy | 150,000 | 315.10 | 47,264,850 |
2014-07-14 | REGN | Buy | 150,000 | 317.06 | 47,558,250 |
2014-07-10 | REGN | Buy | 175,000 | 310.54 | 54,343,800 |
2014-07-08 | REGN | Buy | 153,000 | 312.20 | 47,766,447 |
2014-07-09 | REGN | Buy | 195,000 | 307.80 | 60,021,000 |
2014-07-07 | REGN | Buy | 256,700 | 313.46 | 80,464,411 |
2014-07-03 | REGN | Buy | 100,000 | 311.20 | 31,120,000 |
2014-07-01 | REGN | Buy | 212,400 | 295.93 | 62,855,319 |
2014-07-02 | REGN | Buy | 212,400 | 305.58 | 64,905,616 |
2014-06-27 | REGN | Buy | 50,000 | 275.22 | 13,760,950 |
2014-06-30 | REGN | Buy | 212,400 | 280.15 | 59,504,921 |
2014-05-19 | REGN | Buy | 190,751 | 299.45 | 57,119,623 |
2014-03-28 | REGN | Buy | 306,945 | 307.76 | 94,466,314 |
2014-03-27 | REGN | Buy | 306,945 | 310.48 | 95,301,511 |
2014-03-21 | REGN | Buy | 305,115 | 322.74 | 98,471,899 |
2014-03-24 | REGN | Buy | 306,945 | 306.70 | 94,140,031 |
2014-03-20 | REGN | Buy | 57,957 | 327.72 | 18,993,841 |
2014-03-19 | REGN | Buy | 9,746 | 327.57 | 3,192,497 |
2014-03-14 | REGN | Buy | 55,583 | 327.98 | 18,230,223 |
2014-03-17 | REGN | Buy | 60,128 | 328.59 | 19,757,639 |
2014-03-12 | REGN | Buy | 220,995 | 332.33 | 73,444,373 |
2014-03-10 | REGN | Buy | 199,822 | 328.89 | 65,718,658 |
2014-03-11 | REGN | Buy | 180,710 | 332.15 | 60,023,368 |
2014-03-06 | REGN | Buy | 80,404 | 339.23 | 27,275,609 |
2014-03-07 | REGN | Buy | 69,873 | 316.13 | 22,088,741 |
2014-03-07 | REGN | Buy | 241,818 | 333.50 | 80,646,061 |
2014-03-03 | REGN | Buy | 251,594 | 334.42 | 84,137,310 |
2014-02-07 | REGN | Buy | 21,986 | 287.22 | 6,314,906 |
2014-02-06 | REGN | Buy | 146,525 | 285.61 | 41,849,005 |
2014-02-04 | REGN | Buy | 190,286 | 285.07 | 54,245,591 |
2014-02-05 | REGN | Buy | 206,978 | 281.27 | 58,217,322 |
2014-01-31 | REGN | Buy | 10,914 | 288.13 | 3,144,661 |
2014-02-03 | REGN | Buy | 198,058 | 284.15 | 56,278,180 |
2014-01-27 | REGN | Buy | 74,685 | 272.68 | 20,365,329 |
2014-01-28 | REGN | Buy | 83,235 | 276.68 | 23,029,709 |
Table 7. Insider trading of Regulus Therapeutics Inc. (RGLS) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-02-04 | RGLS | Buy | 1,303,780 | 7.67 | 9,999,992 |
Table 8. Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-05-31 | ALNY | Buy | 297,501 | 71.87 | 21,381,396 |
2016-02-01 | ALNY | Buy | 205,030 | 69.75 | 14,300,842 |
2015-01-29 | ALNY | Buy | 97,118 | 95.00 | 9,226,210 |
2015-01-22 | ALNY | Buy | 196,251 | 9,317.00 | 1,828,470,567 |
2015-01-26 | ALNY | Buy | 647,448 | 95.00 | 61,507,560 |
2014-03-25 | ALNY | Buy | 344,448 | 66.88 | 23,036,682 |
Table 9. Insider trading of Voyager Therapeutics, Inc. (VYGR) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-11-16 | VYGR | Buy | 125,000 | 14.00 | 1,750,000 |
Table 10. Insider trading of Translate Bio, Inc. (TBIO) by Sanofi
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-09-14 | TBIO | Buy | 71,983,597 | 38.00 | 2,735,376,686 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Sanofi
(10% Owner of Translate Bio, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.